Loading…
← CockpitCompetitor Analysis › 300171.SZ Tofflon Science and Technology Group Co., Ltd. Class AOpen in the cockpit ↗

Tofflon Science and Technology Group Co., Ltd. Class A300171.SZCompetitor analysis, valuation and peers

China · CNY·Industrials›Industrial Machinery

Chinese maker of pharmaceutical and biopharma production equipment — freeze dryers, sterile fill-finish and bioreactor systems.

≈ A Chinese IMA/Bausch+StrobelMomentum leader 86
Mkt cap
$1.57B
US dollars, full cap
Free float
53%
of shares outstanding
$/day
$31.2M
20-day average traded
Fwd P/E
34.7×
forward earnings
ROIC−WACC
-2.7 pp
WACC 9.5%
Hurdle
-6 pp
Req g minus delivered
Next earnings
174 days
29 Apr 2027
Close · CNYCN¥13.69
1D-3.7%
1W+0.6%
1M-14.2%
3M+12.0%
6M+4.3%
YTD-12.8%
1Y-7.6%
ATR %6.0%
52w lowhigh32.8% off high

What Tofflon Science and Technology does

Chinese maker of pharmaceutical and biopharma production equipment — freeze dryers, sterile fill-finish and bioreactor systems.

Sells freeze-drying and fill-finish lines as large project orders, often with installation and validation work, so income comes in lumps tied to drugmakers' plant investments and recognised after customer acceptance.

In one line: A Chinese IMA/Bausch+Strobel.

Products and services

  • Freeze dryers (lyophilizers)
  • Sterile fill-finish lines
  • Bioreactors

Customers

  • Vaccine and biopharma manufacturers

Where it sits in the supply chain

  • Health Care
  • Pharma manufacturing equipment
  • Sterile processing/freeze-drying

What could go right

  • Biopharma and vaccine manufacturing capacity expansion

What could go wrong

  • Cyclical pharma capex; export/geopolitical restrictions on biotech equipment

Moat: narrow (process know-how, customer qualification). Equipment must be validated within GMP-regulated pharma production lines, creating switching friction.

Headquarters: Shanghai, China · Founded: 1998 · Employees: 5,479

Named competitors

  • IMA Group private or unlisted
  • Bausch+Strobel private or unlisted
  • Syntegon private or unlisted

Tofflon Science and Technology at a glance

Size Tofflon Science and Technology (300171.SZ) is a China Industrials company (Industrial Machinery) with a market value of $1.57B, the 1566th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥13.69 on 6 Nov 2026.

Performance Over six months the shares gained 4.3%, against -17.4% for the median peer and -16.4% for the China market (cap-weighted) — 3rd highest of 20 in its peer set.

Growth Revenue fell 1.5% over the last twelve months (peer median +14.4%); the operating margin is 5.5% (peer median 8.5%).

Valuation It trades at 34.7× forward earnings against a peer median of 23.3× (6th most expensive of 17).

Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -6 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.7 points below its cost of capital (9.5% WACC).

Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010012011 May 202611 Aug 20266 Nov 2026300171.SZ 104Peer median 81
Six months, rebased to 100: Tofflon Science and Technology against the median of its 20 peers (local-currency closes).

Tofflon Science and Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥5.15BCN¥5.21BCN¥4.99BCN¥5.61BCN¥5.44B
Revenue growth—+4%-11%+3%—
Gross profitCN¥1.67BCN¥1.42BCN¥1.37BCN¥1.89BCN¥2.06B
EBITDAn/aCN¥317MCN¥209MCN¥683MCN¥935M
Net incomeCN¥265MCN¥200MCN¥194MCN¥600MCN¥847M
Free cash flowCN¥685MCN¥517MCN¥389M-CN¥1.01B-CN¥475M
Capital expenditureCN¥124MCN¥271MCN¥499MCN¥695MCN¥726M
Total debtCN¥114MCN¥161MCN¥78.1MCN¥49.0MCN¥47.1M

Quarterly statements and history in the cockpit →

Tofflon Science and Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%-40%-20%0%6006196032036103HLIO68813930018560188200294360358364073016031651KSB002645603698TVK6548600343688028300171.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Tofflon Science and Technology is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%20×40×60×6032036103HLIO68813930018560188200294360358364071651KSB002645603698TVK6548688028300171.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Tofflon Science and Technology is the large dot.

Capital: growth delivered against growth the price implies

0%+20%0%20%600619603203HLIO68813930018560188264073016031651KSBTVK300171.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Tofflon Science and Technology is the large dot.

Tofflon Science and Technology competitors and peer comparison

How Tofflon Science and Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Tofflon Science and Technology against its 20 peers (data as of 6 Nov 2026)
Measure300171.SZPeer medianRank in peer set
1-month return-14.2%-10.3%9th lowest of 21
6-month return+4.3%-17.4%3rd highest of 20
Distance from 52-week high-32.8%-47.3%4th highest of 21
Revenue growth (TTM)-1.5%+14.4%4th lowest of 21
Operating margin5.5%8.5%7th lowest of 21
Forward P/E34.7×23.3×6th most expensive of 17
Growth the price implies (Req g, 7 yrs)8.0%10.9%4th least demanding of 13
Growth delivered (Del g)+14.0%+10.3%5th highest of 13
Hurdle (Req g minus delivered)-6.0 pp+1.5 pp4th least demanding of 13
ROIC minus cost of capital-2.7 pp-2.5 pp10th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Tofflon Science and Technology 300171.SZChina$1.57B+4%-2%6%34.7×8.0%+14.0%
Shanghai Highly (Group) 600619.SSChina$1.57B-33%+3%3%n/a8.6%+13.1%
Quick Intelligent Equipment 603203.SSChina$1.57B-12%+20%21%39.3×28.7%+15.2%
Okuma 6103.TJapan$1.56B-16%+15%9%10.4×n/an/a
Helios Technologies HLIOUnited States$1.56B-30%+14%13%14.6×11.2%+9.9%
Qingdao Haier Biomedical 688139.SSChina$1.58B+6%+12%9%36.5×20.7%+10.8%
Tongyu Heavy Industry 300185.SZChina$1.59B-17%+6%4%43.7×6.3%+3.1%
Ningbo Haitian Precision Machinery 601882.SSChina$1.56B-1%+19%11%20.0×12.8%+15.6%
Hunan Yujing Machinery 002943.SZChina$1.60B-42%-36%-23%37.5×n/an/a
Zhejiang Jiecang Linear Motion Technology 603583.SSChina$1.60B-4%+5%8%26.0×n/an/a
CKD 6407.TJapan$1.54B-40%+11%14%10.8×12.4%+8.1%
Jirfine Intelligent Equipment 301603.SZChina$1.53B-12%+43%15%n/a28.5%+26.7%
Precision Tsugami (China) 1651.HKHong Kong$1.62B-35%+24%28%7.7×-13.9%+9.8%
KSB SE & Co. KGaA KSB.DEGermany$1.63B-3%+2%7%10.3×-3.2%+6.6%
Rokae (Shandong) Robotics 3752.HKHong Kong$1.52Bn/a+105%-5%n/an/an/a
Jiangsu Huahong Technology Stock 002645.SZChina$1.52B-38%+57%5%20.6×n/an/a
Changzheng Engineering Technology 603698.SSChina$1.51B-57%-4%7%33.0×n/an/a
TerraVest Industries TVK.TOCanada$1.64B-17%+46%8%26.4×10.6%+35.1%
Chang Wah Technology 6548.TWOTaiwan$1.65B+9%+25%15%17.5×9.2%+6.8%
Shaanxi Aerospace Power Hi-Tech 600343.SSChina$1.65B-50%-15%-24%n/an/an/a
Beijing Worldia Diamond Tools 688028.SSChina$1.66B-37%+22%16%71.0×n/an/a

Questions

Who are Tofflon Science and Technology's main competitors?
Named competitors: IMA Group (private or unlisted), Bausch+Strobel (private or unlisted), Syntegon (private or unlisted). The cockpit's measured peer set (industry) also includes Shanghai Highly (Group) (600619.SS), Quick Intelligent Equipment (603203.SS), Okuma (6103.T), Helios Technologies (HLIO), Qingdao Haier Biomedical (688139.SS), Tongyu Heavy Industry (300185.SZ).
Is Tofflon Science and Technology expensive compared with its peers?
On forward p/e it trades at 34.7× against a peer median of 23.3×, 6th most expensive of 17 in its peer set. For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -6 pp: the price already allows for a slowdown.
How has Tofflon Science and Technology stock performed?
Over six months to 6 Nov 2026 the shares returned +4.3% against -17.4% for the median peer; over one year -7.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.